Status:
COMPLETED
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Lead Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Respiratory Distress Syndrome, Adult
Lung Diseases
Eligibility:
All Genders
13+ years
Phase:
PHASE3
Brief Summary
The purposes of this study are to assess rapidly innovative treatment methods in patients with adult respiratory distress syndrome (ARDS) as well as those at risk of developing ARDS and to create a ne...
Detailed Description
BACKGROUND: ARDS affects approximately 150,000 people in the United States each year. Despite 20 years of research into the mechanisms that cause this syndrome and numerous developments in the techno...
Eligibility Criteria
Inclusion Criteria:
- Men and women
- 13 years of age or older
- ARDS or risk factors for ARDS (patients will be considered at risk if they are critically ill and have trauma, sepsis, shock, pneumonia, inhalation injury, drug overdose, pancreatitis, or hypertransfusion)
Key Trial Info
Start Date :
September 1 1994
Trial Type :
INTERVENTIONAL
End Date :
July 1 2004
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00000579
Start Date
September 1 1994
End Date
July 1 2004
Last Update
March 23 2016
Active Locations (21)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California
San Francisco, California, United States, 94143
2
University of Colorado Health Sciences Center
Denver, Colorado, United States, 80262
3
University of Chicago
Chicago, Illinois, United States, 60637
4
Louisiana State University
New Orleans, Louisiana, United States, 70112